Cryo Cell International CCEL Insider Ownership

Updated Nov 5, 2026

In the last 12 months, insiders at Cryo Cell International neither bought nor sold shares on the open market.

• Away from the open market, CCEL insiders received 11.97K shares in stock awards and acquired 7.5K shares through option exercises and conversions over the last 12 months.
• Business Quant data puts insider holdings in CCEL at 2.85Mn shares across insiders' latest Form 4 filings, unchanged from 2.85Mn shares at the end of Q2 2026 and up 1.03% from 2.82Mn shares at the end of Q3 2025.
• Indirect holdings, through trusts, partnerships, family members and other entities, make up 54.97% (1.57Mn shares) of Cryo Cell International's insider total, with the other 45.03% (1.28Mn shares) held directly.
• Holdings in Cryo Cell International stock are reported by 5 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
• Cryo Cell International's top three insider holders by shares held are David Portnoy (Chairman, Co CEO, 1.7Mn shares), Mark L. Portnoy (Co-CEO, 935.77K shares) and Oleg Mikulinsky (Chief Information Officer, 104.35K shares).
• The largest insider, David Portnoy, holds 59.65% of CCEL's insider total.
• Institutional holders reported 6.89% of Cryo Cell International's outstanding shares for Q2 2026; insiders' latest Form 4 filings put their stake at about 35.38%, and other investors, including the public, hold the remaining 57.73%.
• Over the past 12 months, 6 insiders reported transactions in Cryo Cell International stock in 11 Form 4 filings.
• This summary of Cryo Cell International insider activity covers Form 4 filings through October 28, 2026.